Related Experiment Video
Updated: Mar 22, 2026
10:45
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
Published on: May 25, 2017
15.3K
New therapeutic targets in alcoholic hepatitis
Diana Arsene1, Omar Farooq1, Ramon Bataller2,3
1Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, 7340.A Medical Biomolecular Research Building, Chapel Hill, NC, 27599, USA.
Hepatology International
|April 14, 2016
Summary
Alcoholic hepatitis (AH), a severe form of alcoholic liver disease (ALD), has high mortality. This review explores AH pathogenesis and translational tools to identify new therapeutic targets for this critical condition.
Area of Science:
- Hepatology
- Gastroenterology
- Translational Medicine
Background:
- Alcoholic liver disease (ALD) is a major global health concern, encompassing a range of conditions from fatty liver to cirrhosis.
- Alcoholic hepatitis (AH) represents the most severe manifestation of ALD, characterized by acute liver failure and high mortality rates (20-50% within 3 months).
- Current therapeutic options for AH are limited, highlighting an urgent need for novel treatment strategies.
Purpose of the Study:
- To review the clinical presentation, pathogenesis, and available translational tools for alcoholic hepatitis (AH).
- To identify potential molecular and cellular targets for the development of new therapeutic interventions for AH.
- To bridge the gap between preclinical research and clinical application for AH treatment.
Main Methods:
- Comprehensive literature review of clinical studies, preclinical models, and molecular/cellular research related to alcoholic hepatitis (AH).
- Analysis of pathogenesis mechanisms at the molecular and cellular levels.
- Evaluation of existing translational tools, including human samples and animal models, for AH research.
Main Results:
- Alcoholic hepatitis (AH) presents with jaundice and complications of liver insufficiency and portal hypertension.
- Key molecular and cellular pathways involved in AH pathogenesis have been elucidated.
- Existing translational models offer valuable platforms for testing novel therapeutic strategies.
Conclusions:
- Effective therapeutic interventions for alcoholic hepatitis (AH) are critically needed due to its severe prognosis.
- Understanding AH pathogenesis at a molecular level is crucial for identifying new drug targets.
- Further development and utilization of translational tools are essential for advancing AH treatment.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
254
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
254
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
65
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
01:26Targets for Drug Action: Overview
11.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.2K
01:25Hepatitis
27
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
27
01:30Enzyme Inhibition
94.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
94.7K
01:27CNS Depressants: Alcohol and Nicotine
1.5K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.5K